OSA

Vivos Therapeutics Announces Formation of New Medical Consortium to Advance the Company’s Technology for Obstructive Sleep Apnea

Drs. Clete Kushida of Stanford and Cecilia Wu of University of Alberta to lead...

FDA Grants 510(k) Market Clearance to Vivos Therapeutics’ mmRNA Oral Appliance for Treating Mild to Moderate Sleep Apnea

Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused...

Vivos Therapeutics Opens State of the Art International Training Center In Denver

Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused...

26% of Americans Aren’t Familiar with Obstructive Sleep Apnea

Nearly 70% of Americans who sleep with a bed partner report that their partner...

Dental Sleep Medicine Can Improve Overall Health

Dental sleep medicine appears in many guises for the treatment of sleep-disordered breathing, including...

Apnea Treatment May Reduce Dementia Risks

Older adults who received positive airway pressure therapy prescribed for obstructive sleep apnea (OSA)...

How to Talk to Your Patients About Sleep Disordered Breathing

We’ve all had it happen. You take the car in for an oil change...

Vivos Therapeutics Establishes Clinical Advisory Board

Vivos Therapeutics has established a clinical advisory board to drive adoption and growth of...

Combat Dental Problems by Treating Sleep Apnea Patients

Sleep is an essential function for the human body. It revives our overall being,...

Obstructive Sleep Apnea Strains the Heart

Longer nocturnal respiratory events in patients with obstructive sleep apnea (OSA) cause higher immediate...